NCT00593138View on ClinicalTrials.gov

Study of Dopamine Transporter Receptor Occupancy With Long-acting Dex-methylphenidate

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2009

Conditions
Drug Binding to DAT Receptors
Interventions
DRUG

dex-methylphenidate

The drug is administered as a capsule by mouth. Participants are assigned to receive either 20, 30 or 40 mg doses before each scan visit.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00593138 - Study of Dopamine Transporter Receptor Occupancy With Long-acting Dex-methylphenidate | Biotech Hunter | Biotech Hunter